| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735) | Alaunos Therapeutics | 2022-04-04 |
| Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011) (NCT05252676) | Fudan University | 2021-10-01 |
| Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis (NCT04692935) | Jun Wang | 2021-01-01 |
| Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib (NCT04770688) | Shanghai Chest Hospital | 2020-11-19 |
| Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (NCT04557449) | Pfizer | 2020-09-23 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients (NCT04566432) | Geneplus-Beijing Co. Ltd. | 2020-07-01 |
| Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma (NCT03361319) | Royal Marsden NHS Foundation Trust | 2020-07-01 |
| Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy (NCT05245630) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2020-07-01 |
| HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008) (NCT04165759) | Fudan University | 2019-11-18 |
| Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study (NCT04122833) | Konkuk University Medical Center | 2019-09-30 |
| LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT04027946) | National Cancer Institute (NCI) | 2019-09-11 |
| The Detection of EGFR Mutations in Liquid Based Cytology Samples (NCT04086680) | Royal Cornwall Hospitals Trust | 2019-05-07 |
| Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery (NCT06796816) | Azienda USL Reggio Emilia - IRCCS | 2019-04-01 |
| Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer (NCT03298763) | University College, London | 2019-03-05 |
| To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer (NCT03676192) | Celltrion | 2019-02-01 |
| An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung (NCT03371381) | Janssen Research & Development, LLC | 2018-01-02 |
| Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT03184571) | BerGenBio ASA | 2017-10-02 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China (NCT03059641) | Geneplus-Beijing Co. Ltd. | 2017-02-22 |
| ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC (NCT02946216) | First People's Hospital of Hangzhou | 2016-11-01 |
| Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma (NCT02804646) | Anhui Provincial Hospital | 2016-06-01 |
| The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR (NCT02493582) | The First People's Hospital of Changzhou | 2015-07-01 |
| An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors (NCT02616211) | Mayo Clinic | 2014-10-01 |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma (NCT01362790) | National Cancer Institute (NCI) | 2011-05-11 |
| Vaccine Treatment for Advanced Non-Small Cell Lung Cancer (NCT00073398) | NewLink Genetics Corporation | 2003-11-01 |